According to the Market Statsville Group (MSG), theglobal electroretinogram market size is expected to grow from USD 531.8 million in 2021 to USD 109.3 million by 2030, at a CAGR of 8.3% from 2022 to 2030. Electroretinograms (ERGs) are clinical ophthalmic diagnostic tests that assess the retina's electrical activity in response to a light stimulus. The electroretinogram is formed by currents produced directly by retinal neurons and contributions from retinal glia. Ophthalmologists use these electroretinograms to identify the necessity for retinal surgery or other eye procedures such as cataract surgery. It is used to identify individuals with various symptoms, including photophobia, nyctalopia, decreased visual acuity, and field defects.
Constant innovation and an increase in the number of ophthalmology clinics and research facilities drive the market's demand for electroretinograms. Furthermore, the increased incidence of eye ailments such as diabetic retinopathy, glaucoma, retinitis pigmentosa, macular degeneration, cone-rod dystrophy, and other retinal disorders is likely to drive market expansion during the forecast period. Furthermore, the growing demand for early disease detection, greater screen time due to the pandemic, and the fast-growing senior population are likely to drive market expansion.
Request Sample Copy of this Report: https://www.marketstatsville.com/request-sample/electroretinogram-market
COVID-19 Impact on the Global Electroretinogram Market
According to an NCBI study published on PubMed Central, the COVID-19 pandemic can impair retinal function. The size of the retinal veins is linked to the severity of the COVID-19 disease infection. COVID-19 disorders can cause significant alterations in the retina, such as altering the retinal vascular. Furthermore, only a few incidences of retinal adverse effects were documented following the COVID-19 vaccine. Electroretinograms were used to diagnose and monitor the retina's health and other associate